ストックスクリーナーアプリを入手
3.22
0.31%
0.01
前日終値:
$3.21
開ける：
$3.21
24時間の取引高:
816.94K
Relative Volume:
1.85
時価総額：
$389.66M
収益：
$34.16M
当期純損益:
$-50.62M
株価収益率:
-6.3386
EPS:
-0.508
ネットキャッシュフロー:
$703.00K
1週間 パフォーマンス:
+0.94%
1か月 パフォーマンス:
-8.00%
6か月 パフォーマンス:
-30.90%
1年 パフォーマンス:
-46.24%
1日の値動き範囲:
$3.205
$3.27
1週間の範囲:
$3.1609
$3.37
52週間の値動き範囲:
$3.1609
$6.5488
Omniab Inc Stock (OABI) Company Profile
OABI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
3.22 | 389.66M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-04-21 | 開始されました | The Benchmark Company | Buy |
| 2023-04-13 | 開始されました | Craig Hallum | Buy |
| 2023-02-22 | 開始されました | Cowen | Outperform |
| 2023-02-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-20 | 開始されました | Truist | Buy |
| 2022-12-16 | 開始されました | Credit Suisse | Outperform |
| 2022-11-29 | 開始されました | SVB Leerink | Outperform |
| 2022-11-28 | 開始されました | Stifel | Buy |
すべてを表示
Omniab Inc (OABI) 最新ニュース
OmniAb, Inc. (NASDAQ:OABI) Shares Bought by Barclays PLC - Defense World
OmniAb (NASDAQ:OABI) Hits New 52-Week Low – Here’s What Happened - Defense World
OABI stock touches 52-week low at $3.43 amid market challenges - Investing.com Nigeria
OmniAb (NASDAQ:OABI) Hits New 1-Year LowTime to Sell? - MarketBeat
OmniAb Announces Publication of Scientific Paper on Heavy Chain- - GuruFocus.com
FY2024 EPS Estimates for OmniAb Raised by Leerink Partnrs - Defense World
FY2024 EPS Estimates for OmniAb Lifted by Leerink Partnrs - MarketBeat
OmniAb Presents High-Throughput Single B-cell Screening xPlorati - GuruFocus.com
OmniAb, Inc. (NASDAQ:OABI) Shares Sold by Jane Street Group LLC - Defense World
Geode Capital Management LLC Lowers Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Barclays PLC Increases Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Why OmniAb, Inc. (OABI) Is One of the Best Biotech Penny Stocks to Invest in Now? - Insider Monkey
US Penny Stocks To Watch In December 2024 - Simply Wall St
OmniAb (NASDAQ:OABI) Stock Price Up 2.8% – Still a Buy? - Defense World
State Street Corp Grows Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb (NASDAQ:OABI) Shares Up 2.8%Here's What Happened - MarketBeat
With 55% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $542,000 Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Fmr LLC Acquires 13,324 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
First Trust Water ETF (NYSEARCA:FIW) Shares Acquired by Fmr LLC - Defense World
OABI stock touches 52-week low at $3.55 amid market challenges - Investing.com
OmniAb Unveils Revolutionary AI-Powered Antibody Discovery Platform, Launches Advanced OmniHub™ Portal - StockTitan
Tharimmune Advances TH104 Clinical Program: Phase 2 Trial Set for 2025 After Positive Phase 1 Results - StockTitan
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth By Investing.com - Investing.com South Africa
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth - Investing.com India
Charles Schwab Investment Management Inc. Increases Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb (NASDAQ:OABI) Shares Down 5.5%Here's Why - MarketBeat
OmniAb CFO Kurt Gustafson sells $98,587 in stock By Investing.com - Investing.com Nigeria
OmniAb chief legal officer sells $33,130 in shares By Investing.com - Investing.com Nigeria
omniAb CEO Matthew Foehr sells $56,308 in stock By Investing.com - Investing.com Canada
omniAb CEO Matthew Foehr sells $56,308 in stock - Investing.com India
OmniAb chief legal officer sells $33,130 in shares - Investing.com India
OmniAb CFO Kurt Gustafson sells $98,587 in stock - Investing.com
First Sabrepoint Capital Management LP Sells 210,000 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
THARTharimmune, Inc. Latest Stock News & Market Updates - StockTitan
1,000,000 Shares in OmniAb, Inc. (NASDAQ:OABI) Acquired by Murchinson Ltd. - MarketBeat
Single Domain Antibody Platform Market to Reach US$ 86 - GlobeNewswire
OmniAb's SWOT analysis: antibody discovery firm's stock faces growth hurdles - Investing.com
35,081 Shares in OmniAb, Inc. (NASDAQ:OABI) Bought by Atria Investments Inc - Defense World
Promising US Penny Stocks To Watch In November 2024 - Simply Wall St
GSA Capital Partners LLP Decreases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
Janus Henderson Group PLC's Strategic Acquisition in OmniAb Inc - GuruFocus.com
OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates - MSN
Benchmark Reiterates "Buy" Rating for OmniAb (NASDAQ:OABI) - MarketBeat
OmniAb Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
OmniAb's (OABI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Omniab Inc (OABI) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):